赛诺菲消费者医疗印度有限公司 (SCHIL) 从赛诺菲印度分离,并于2024年6月1日首次登陆股票交易所. Sanofi Consumer Healthcare India Ltd (SCHIL) demerged from Sanofi India and debuted on stock exchanges on June 1, 2024.

2024年6月1日,印度Sanofi消费者保健有限公司(SCHIL)与印度Sanofi公司进行合并后,在孟买证券交易所和国家证券交易所上揭幕,于2024年6月1日生效。 Sanofi Consumer Healthcare India Ltd (SCHIL) has debuted on the Bombay Stock Exchange and National Stock Exchange following its demerger from Sanofi India, effective June 1, 2024. 这项举措得到国家公司法法庭批准,允许SCHIL独立运作,重点是消费者保健,其组合包括Allegra和Combiflam等品牌。 This move, approved by the National Company Law Tribunal, allows SCHIL to operate independently, focusing on consumer healthcare with a portfolio that includes brands like Allegra and Combiflam. 该公司的目标是通过创新和趋势适应,提高市场地位,推动可持续增长。 The company aims to enhance its market position and drive sustainable growth through innovation and trend adaptation.